Lympho Bob

A blog about Cancer in general, and Follicular Lymphoma in particular

Sunday, May 28, 2023

Age, Stage, and Status in Predicting FL Survival

›
I want to share some research that was presented at the International Society for Pharmacoeconomics and Outcomes Research conference a coup...
1 comment:
Tuesday, May 23, 2023

Some Upcoming LRF Opportunities

›
As you probably know, I like to highlight some of the educational opportunities offered by LRF, the Lymphoma Research Foundation. I think th...
Friday, May 19, 2023

A Few Quick Updates

›
 A quick post today, with a few short items: 1) First, remember that there are only a few more days to endorse me (vote for me) for the Soci...
Monday, May 15, 2023

Vote for Me -- Social Health Awards

›
It's that time of year again -- the Social Health Awards! Actually, it's about a month earlier than in the past, but still -- it...
Wednesday, May 10, 2023

CAR-T Approved in Europe (for Some Patients with FL)

›
The CAR-T treatment known as Liso-cel (L isocabtagene Maraleucel) was approved by the European Commission last week for some patients with a...
Friday, May 5, 2023

Subcutaneous Rituxan for FL

›
Interesting research in The Journal of Clinical Oncology on how Rituxan is delivered to Follicular Lymphoma patients with low tumor burden....
Sunday, April 30, 2023

Surviving (or Whatever You Call It)

›
Earlier this week, I read an interesting piece called " Surviving Blood Cancer: Lessons from a TV Show ," by Ramae Hamrin, publish...
4 comments:
‹
›
Home
View web version

Contributors

  • Lymphomaniac
  • Lymphomaniac
Powered by Blogger.